A recent report suggested that defective signaling of IL-10, an anti-inflammatory cytokine, in a lipopolysaccharide-induced colitis of mice and in macrophages of IBD patients led to dysregulated activation of the NLRP3 inflammasome and production of IL-1β31. The gene discussed is IL10; the disease is inflammatory bowel disease.